Samsung Biologics

CDMO focused on biologics development & manufacturing services

placeIncheon, Incheon, South Korea calendar_todayFounded 2011 groups4,532 employees language samsungbiologics.com

Innovation

22 patent families (4 granted) — focus: Chemistry & metallurgy, Operations & transport, Human necessities, Electricity & electronics; filing pace accelerating. Cited 124 times.

YearFilings
20161
20171
20223
20233
202411
20258
20267

Investor mix

2 investors on record.

Investor typeCountShare
Private equity150%
Other / undisclosed150%
Coming soon